OA
CL icon

Oxbow Advisors’s Colgate-Palmolive CL Stock Holding History

Oxbow Advisors’s Portfolio CL Stock Details CL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.69M Buy
40,246
+326
+0.8% +$28.5K 0.3% 93
2026
Q1 		$3.4M Buy
39,920
+261
+0.7% +$23.3K 0.29% 90
2025
Q4 		$3.13M Sell
39,659
-34,327
-46% -$2.69M 0.28% 99
2025
Q3 		$5.91M Buy
73,986
+42,267
+133% +$3.61M 0.55% 50
2025
Q2 		$2.88M Buy
31,719
+1,391
+5% +$127K 0.32% 79
2025
Q1 		$2.84M Buy
30,328
+691
+2% +$61.9K 0.3% 71
2024
Q4 		$2.69M Buy
+29,637
New +$2.83M 0.32% 72

Other funds holding CL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Oxbow Advisors's CL Position: Q2 2026 in Review

Oxbow Advisors increased its Colgate-Palmolive (CL) stake by 0.82% in Q2 2026, buying an estimated $28.5K and bringing the position to 40,246 shares worth $3.69M. The position accounts for 0.3% of the portfolio, ranked #93.

Oxbow Advisors first reported a position in CL in Q4 2024 and has held it in 7 quarters since. The position peaked at $5.91M in Q3 2025. 2,017 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Oxbow Advisors held 40,246 shares of Colgate-Palmolive worth $3.69M as of Q2 2026.
  • Oxbow Advisors bought 326 Colgate-Palmolive shares in Q2 2026, an estimated $28.5K.
  • Colgate-Palmolive made up 0.3% of Oxbow Advisors's portfolio in Q2 2026, its #93 holding.
  • Oxbow Advisors first reported a position in Colgate-Palmolive in Q4 2024 and has held it in 7 quarters since.
  • Oxbow Advisors's Colgate-Palmolive position peaked at $5.91M in Q3 2025.
  • 2,017 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Oxbow Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.